InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Alam Kamran, Chief Financial Officer. Director active across 2 companies, notably Taysha Gene Therapies, Inc.. Aggregated, 13 filings have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €855k. History available since 18 August 2021. The latest transaction was filed on 26 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
78,968 shares@ US$4.7535.3% of flowCommon StockSEC:0001793412-26-000008:0
23,849 shares@ US$4.6110.3% of flowCommon StockSEC:0001793412-26-000008:1
29,843 shares@ US$1.695.2% of flowCommon StockSEC:0001415889-25-007997:0
431,000 shares0Common StockSEC:0001415889-25-000595:0
1,288 shares@ US$1.510.2% of flowCommon StockSEC:0001415889-24-002809:0
590,413 shares0Common StockSEC:0001209191-24-000811:0
33,000 shares@ US$2.337.9% of flowCommon StockSEC:0001209191-23-047323:0
6,230 sharesCommon StockSEC:0001209191-23-033681:0
18,691 sharesCommon StockSEC:0001209191-23-007396:0
3,325 shares@ US$3.471.3% of flowCommon StockSEC:0001209191-22-047353:0
7,476 shares@ US$3.873.2% of flowCommon StockSEC:0001209191-22-047097:0
11,193 shares@ US$17.350.0097% mcap50.0% of flowCommon StockSEC:0001209191-21-052824:0
11,193 shares@ US$17.3518.4% of flowCommon StockSEC:0001209191-21-052824
13 of 13 declarations
About Alam Kamran
Kamran Alam is the Chief Financial Officer at Taysha Gene Therapies, Inc. He is responsible for the company's financial management, including financial planning and regulatory compliance. Kamran plays a key role in developing financial strategies that support the company's growth. His expertise in finance is essential for ensuring Taysha's financial health.
